Pituitary Neuroendocrine Tumor of PIT1-Lineage — knowledge graph · CancerIndex

Knowledge graph · Cancer

Pituitary Neuroendocrine Tumor of PIT1-Lineage

subtype

Identifier: CI-CAN-00006427
Entity page: /cancer/pituitary-neuroendocrine-tumor-of-pit1-lineage ↗
Edges: 25

Neighbours: 3 drugs10 trials
Drawn: 13 of 13 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Pituitary Neuroendocrine Tumor of PIT1-Lineage investigated in trials for …INVESTIGATED_IN_TRIALSderived3 of 3
→ investigated in trials for	Dexamethasonesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Pituitary Neuroendocrine Tumor of PIT1-Lineage	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Lapatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants

Pituitary Neuroendocrine Tumor of PIT1-Lineage studied in …STUDIED_INderived10 of 22show all (up to 200)
→ studied in	NCT00001595recruiting An Investigation of Pituitary Tumors and Related Hypothalmic Disorders · condition mapped ALIAS · 22 trials mapped (5 active)	—	—	Lactotroph Pituitary Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT07463235Phase 3 · recruiting Safety and Potency of a High Cabergoline Dosage in Microprolactinomas · condition mapped ALIAS · 22 trials mapped (5 active)	—	—	Lactotroph Pituitary Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT07268183recruiting How Estrogen Fluctuations Before Diagnosis Affect the Size Prolactin-secreting Tumors · condition mapped ALIAS · 22 trials mapped (5 active)	—	—	Lactotroph Pituitary Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT06936813active not recruiting The PROMISE Survey · condition mapped ALIAS · 22 trials mapped (5 active)	—	—	Lactotroph Pituitary Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT04106531terminated Validation of a Quality of Life Metric "Prolac-10" · condition mapped ALIAS · 22 trials mapped (5 active)	—	—	Lactotroph Pituitary Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT07045935Phase 4 · recruiting Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment · condition mapped ALIAS · 22 trials mapped (5 active)	—	—	Lactotroph Pituitary Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT03038308Phase 1/Phase 2 · completed Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole · condition mapped ALIAS · 22 trials mapped (5 active)	—	—	Lactotroph Pituitary Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT05236829completed Exercise Capacity and Physical Activity Level in Prolactinoma Patients · condition mapped ALIAS · 22 trials mapped (5 active)	—	—	Lactotroph Pituitary Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT04107480Phase 4 · unknown PRolaCT - Three Prolactinoma RCTs · condition mapped ALIAS · 22 trials mapped (5 active)	—	—	Lactotroph Pituitary Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT03457389NA · unknown Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma · condition mapped ALIAS · 22 trials mapped (5 active)	—	—	Lactotroph Pituitary Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →